Susquehanna Fundamental Investments’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $568K | Hold |
28,334
| – | – | 0.02% | 532 |
|
|
2025
Q1 | $558K | Buy |
+28,334
| New | +$558K | 0.01% | 817 |
|
|
2021
Q1 | – | Sell |
-2,337
| Closed | -$206K | – | 1555 |
|
|
2020
Q4 | $206K | Sell |
2,337
-813
| -26% | -$71.7K | ﹤0.01% | 1351 |
|
|
2020
Q3 | $256K | Buy |
3,150
+1,250
| +66% | +$102K | 0.01% | 1115 |
|
|
2020
Q2 | $210K | Buy |
+1,900
| New | +$210K | 0.01% | 833 |
|